LCTX LINEAGE CELL THERAPEUTICS INC
Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · after market close
What 9 analyst firms say about LINEAGE CELL THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 1 report on LCTX from 1 analyst firm in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 3 Sep 2026 | 4.00 USD |
| Baird | Jack K Allen | Buy | 1 Apr 2026 | 5.00 USD |
| Canaccord Genuity | John L Newman | Buy | 28 Apr 2026 | 9.00 USD |
| Craig-Hallum | Albert Lowe | Buy | 6 Mar 2026 | 3.00 USD |
| D Boral Capital | Patrick Mccann | Buy | 21 May 2026 | 3.00 USD |
| H.C. Wainwright | Joseph Pantginis | Buy | 14 Jul 2026 | 9.00 USD |
| Maxim Group | Michael Okunewitch | Buy | 15 Mar 2026 | 3.00 USD |
| Raymond James | Sean Mccutcheon | Hold | 12 May 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:03 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.